327 related articles for article (PubMed ID: 31968994)
1. Nicotinamide Adenine Dinucleotide Phosphate Oxidase and Neurodegenerative Diseases: Mechanisms and Therapy.
Hou L; Zhang L; Hong JS; Zhang D; Zhao J; Wang Q
Antioxid Redox Signal; 2020 Aug; 33(5):374-393. PubMed ID: 31968994
[No Abstract] [Full Text] [Related]
2. NADPH Oxidase Inhibition: Preclinical and Clinical Studies in Diabetic Complications.
Urner S; Ho F; Jha JC; Ziegler D; Jandeleit-Dahm K
Antioxid Redox Signal; 2020 Aug; 33(6):415-434. PubMed ID: 32008354
[No Abstract] [Full Text] [Related]
3. NADPH Oxidase Inhibition in Fibrotic Pathologies.
Bernard K; Thannickal VJ
Antioxid Redox Signal; 2020 Aug; 33(6):455-479. PubMed ID: 32129665
[No Abstract] [Full Text] [Related]
4. The NADPH Oxidase Family and Its Inhibitors.
Chocry M; Leloup L
Antioxid Redox Signal; 2020 Aug; 33(5):332-353. PubMed ID: 31826639
[No Abstract] [Full Text] [Related]
5. New insights on NOX enzymes in the central nervous system.
Nayernia Z; Jaquet V; Krause KH
Antioxid Redox Signal; 2014 Jun; 20(17):2815-37. PubMed ID: 24206089
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological intervention in oxidative stress as a therapeutic target in neurological disorders.
Sharma S; Advani D; Das A; Malhotra N; Khosla A; Arora V; Jha A; Yadav M; Ambasta RK; Kumar P
J Pharm Pharmacol; 2022 Apr; 74(4):461-484. PubMed ID: 34050648
[TBL] [Abstract][Full Text] [Related]
7. The Role of NADPH Oxidases and Oxidative Stress in Neurodegenerative Disorders.
Tarafdar A; Pula G
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30513656
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting the Activity of NADPH Oxidase in Cancer.
Konaté MM; Antony S; Doroshow JH
Antioxid Redox Signal; 2020 Aug; 33(6):435-454. PubMed ID: 32008376
[No Abstract] [Full Text] [Related]
9. Current status of NADPH oxidase research in cardiovascular pharmacology.
Rodiño-Janeiro BK; Paradela-Dobarro B; Castiñeiras-Landeira MI; Raposeiras-Roubín S; González-Juanatey JR; Alvarez E
Vasc Health Risk Manag; 2013; 9():401-28. PubMed ID: 23983473
[TBL] [Abstract][Full Text] [Related]
10. NADPH oxidases: novel therapeutic targets for neurodegenerative diseases.
Gao HM; Zhou H; Hong JS
Trends Pharmacol Sci; 2012 Jun; 33(6):295-303. PubMed ID: 22503440
[TBL] [Abstract][Full Text] [Related]
11. Magnesium isoglycyrrhizinate alleviates fructose-induced liver oxidative stress and inflammatory injury through suppressing NOXs.
Yang YZ; Liu ZH; Wang SC; Zhang XQ; Xu HJ; Yang L; Kong LD
Eur J Pharmacol; 2020 Sep; 883():173314. PubMed ID: 32619679
[TBL] [Abstract][Full Text] [Related]
12. The Dual Role of Reactive Oxygen Species-Generating Nicotinamide Adenine Dinucleotide Phosphate Oxidases in Gastrointestinal Inflammation and Therapeutic Perspectives.
Dang PM; Rolas L; El-Benna J
Antioxid Redox Signal; 2020 Aug; 33(5):354-373. PubMed ID: 31968991
[No Abstract] [Full Text] [Related]
13. MicroRNA Targeting Nicotinamide Adenine Dinucleotide Phosphate Oxidases in Cancer.
Kushwaha PP; Gupta S; Singh AK; Prajapati KS; Shuaib M; Kumar S
Antioxid Redox Signal; 2020 Feb; 32(5):267-284. PubMed ID: 31656079
[No Abstract] [Full Text] [Related]
14. Reactive oxygen species, vascular Noxs, and hypertension: focus on translational and clinical research.
Montezano AC; Touyz RM
Antioxid Redox Signal; 2014 Jan; 20(1):164-82. PubMed ID: 23600794
[TBL] [Abstract][Full Text] [Related]
15. Molecular insights of NADPH oxidases and its pathological consequences.
Waghela BN; Vaidya FU; Agrawal Y; Santra MK; Mishra V; Pathak C
Cell Biochem Funct; 2021 Mar; 39(2):218-234. PubMed ID: 32975319
[TBL] [Abstract][Full Text] [Related]
16. NADPH oxidases and inflammatory bowel disease.
Lam G; Apostolopoulos V; Zulli A; Nurgali K
Curr Med Chem; 2015; 22(17):2100-9. PubMed ID: 25876884
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress, Nox isoforms and complications of diabetes--potential targets for novel therapies.
Sedeek M; Montezano AC; Hebert RL; Gray SP; Di Marco E; Jha JC; Cooper ME; Jandeleit-Dahm K; Schiffrin EL; Wilkinson-Berka JL; Touyz RM
J Cardiovasc Transl Res; 2012 Aug; 5(4):509-18. PubMed ID: 22711281
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2.
Carbone F; Teixeira PC; Braunersreuther V; Mach F; Vuilleumier N; Montecucco F
Antioxid Redox Signal; 2015 Aug; 23(5):460-89. PubMed ID: 24635113
[TBL] [Abstract][Full Text] [Related]
19. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) and liver fibrosis: A review.
Mortezaee K
Cell Biochem Funct; 2018 Aug; 36(6):292-302. PubMed ID: 30028028
[TBL] [Abstract][Full Text] [Related]
20. Nicotinamide Adenosine Dinucleotide Phosphate Oxidase-Mediated Signaling in Cardiac Remodeling.
Visnagri A; Oexner RR; Kmiotek-Wasylewska K; Zhang M; Zoccarato A; Shah AM
Antioxid Redox Signal; 2023 Feb; 38(4-6):371-387. PubMed ID: 36656669
[No Abstract] [Full Text] [Related]
[Next] [New Search]
